Work

Abstract 32: Efficacy and tolerability of a enantiomer of Edelfosine (S-CP201) in pancreatic cancer PDX models as a single agent and in combination with approved drugs in clinical use

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-32

Authors: Michael Ahrweiler, Wolfgang Meyer, Axel Zander, Daniel Perrissoud

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409689397

Cites:

Cited by:

Related to: 10